SynthesisFrontiers in allergy2025
Prevalence of shrimp allergy: a meta-analysis based on different diagnostic methods.
Synthesis in Frontiers in allergy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Proteomic Mapping of Allergenic Proteins Reveals Key Differences Between Black Tiger Prawn (Journal of proteome research · 2026Article
- Emerging molecular and environmental biomarkers of shrimp allergy in African Americans in the US.Frontiers in allergy · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Shrimp allergy (SA) represents a significant public health concern, yet its overall prevalence remains unclear. Method: A systematic search of PubMed, Web of Science, and Embase through September 30, 2024 identified 40 studies that reported SA prevalence using self-reported symptoms, physician diagnosis, skin prick tests, specific IgE, or food challenge tests. Results: The pooled prevalence was estimated at 1.90% for self-reported symptomatic SA and 1.94% for self-reported physician-diagnosed SA, while testing via skin prick or specific IgE yielded a prevalence of 2.76%. Notably, symptomatic testing showed a lower prevalence of 0.43%, and food challenge tests confirmed a prevalence of 0.50%. Considerable heterogeneity was observed across studies, with prevalence varying by region and age group, and no publication bias was detected. Conclusion: These findings indicate that the prevalence of SA varies with diagnostic criteria, age, and region, underscoring the need for harmonized diagnostic standards to improve prevalence estimates and guide public health strategies. Systematic Review Registration: identifier [CRD420251003956].
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.